Table 2.

Overall analysis between MMP2 polymorphism (-735 C/T) and susceptibility of cancer

Genetic comparison	Population	OR (95% CI)	P	Heterogeneity		Model
				P	I2
C vs. T	All	0.98 (0.85-1.14)	0.80	<0.001	76.74	Random
	Asian	0.93 (0.79-1.09)	0.37	<0.001	77.89	Random
	Caucasian	1.26 (0.83-1.91)	0.27	0.03	65.60	Random
C/C+C/T vs. T/T	All	0.95 (0.79-1.14)	0.58	0.29	14.40	Fixed
	Asian	0.99 (0.81-1.20)	0.91	0.56	<0.001	Fixed
	Caucasian	0.62 (0.34-1.16)	0.14	0.12	48.90	Fixed
C/C vs. C/T+T/T	All	0.97 (0.81-1.16)	0.71	<0.001	78.20	Random
	Asian	0.90 (0.74-1.09)	0.28	<0.001	79.26	Random
	Caucasian	1.24 (1.01-1.53)	0.040	0.17	40.72	Fixed
C/C vs. C/T	All	0.99 (0.80-1.15)	0.63	<0.001	76.41	Random
	Asian	0.89 (0.73-1.07)	0.22	<0.001	76.84	Random
	Caucasian	1.30 (1.05-1.62)	0.015	0.42	<0.001	Fixed
C/C vs. T/T	All	0.90 (0.75-1.09)	0.29	0.12	30.71	Fixed
	Asian	0.93 (0.76-1.14)	0.48	0.20	25.38	Fixed
	Caucasian	0.66 (0.35-1.23)	0.19	0.12	48.76	Fixed

OR, odds ratio; Bold numbers indicant significant association with risk of cancer.